Skoči na glavni sadržaj

Medicina familiaris Croatica : časopis Hrvatske udružbe obiteljske medicine, Vol. 27 No. 1-2, 2019.

Ostalo

Indications for NOAC discontinuation according to bleeding risks - case report

Nada Ivičević orcid id orcid.org/0000-0003-4759-7302 ; Dom zdravlja Splitsko-dalmatinske županije
Marion Tomičić orcid id orcid.org/0000-0003-2148-3227 ; Medicinski fakultet Sveučilišta u Splitu, Split, Hrvatska

Puni tekst: hrvatski pdf 262 Kb

str. 59-65

preuzimanja: 641

citiraj

Sažetak


Vitamin K antagonists (eg warfarin) and new oral anticoagulants (NOAC) are used to prevent stroke and other embolic accidents in patients with non-valvular atrial fibrillation and in the management and prevention of venous thromboembolism. The choice and dosage of NOACs depends on renal function. Threfore it is necessary to determine creatinine clearance before their introduction. Special caution must be paid to patients with comorbidity and to drug interactions. Treatment with NOACs is particular challenge in the cases such as a major bleeding or surgical intervention.

Ključne riječi

anticoagulants; vitamin K – antagonists; warfarin; stroke; atrial fibrillation; preoperative care

Hrčak ID:

230751

URI

https://hrcak.srce.hr/230751

Datum izdavanja:

20.12.2019.

Podaci na drugim jezicima: hrvatski

Posjeta: 2.013 *